|Chemical and physical data|
|Molar mass||418.423 g/mol g·mol−1|
|3D model (JSmol)|
BTS 74,398 is a centrally acting stimulant drug which was developed for the treatment of Parkinson's disease. It inhibits the synaptic reuptake of dopamine, serotonin and noradrenaline, making it a triple reuptake inhibitor. It was effective in animal models of Parkinson's disease, but was unsuccessful in human trials.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|
|This article about an amine is a stub. You can help Wikipedia by expanding it.|